WDFY2
WD repeat and FYVE domain-containing protein 2
Also known as: WDFY2_HUMAN, ZFYVE22
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q96P53
- Gene
- WDFY2
- Ensembl
- ENSG00000139668
- Chromosome
- 13
- Canonical length
- 400 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Vesicles
- Quaternary structure
- Homodimer
OverviewNCBI Gene
This gene encodes a protein that contains two WD domains and an FYVE zinc finger region. The function of this gene is unknown. An alternatively spliced transcript variant of this gene may exist. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
400 residues, UniProt reviewed canonical sequence.
>Q96P53|WDFY2
1 MAAEIQPKPL TRKPILLQRM EGSQEVVNMA VIVPKEEGVI SVSEDRTVRV WLKRDSGQYW
61 PSVYHAMPSP CSCMSFNPET RRLSIGLDNG TISEFILSED YNKMTPVKNY QAHQSRVTMI
121 LFVLELEWVL STGQDKQFAW HCSESGQRLG GYRTSAVASG LQFDVETRHV FIGDHSGQVT
181 ILKLEQENCT LVTTFRGHTG GVTALCWDPV QRVLFSGSSD HSVIMWDIGG RKGTAIELQG
241 HNDRVQALSY AQHTRQLISC GGDGGIVVWN MDVERQETPE WLDSDSCQKC DQPFFWNFKQ
301 MWDSKKIGLR QHHCRKCGKA VCGKCSSKRS SIPLMGFEFE VRVCDSCHEA ITDEERAPTA
361 TFHDSKHNIV HVHFDATRGW LLTSGTDKVI KLWDMTPVVSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against WDFY2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.24
- Highest tissue expression
- 17 nTPM
Expression across tissuesHPA
Tissue
- skin: 17 nTPM
- pancreas: 15 nTPM
- bone marrow: 14 nTPM
- parathyroid gland: 14 nTPM
- adrenal gland: 10 nTPM
- esophagus: 9 nTPM
Single-cell type
- adrenal cortex cells: 710 nCPM
- pancreatic acinar cells: 601 nCPM
- distal convoluted tubule cells: 582 nCPM
- monocyte progenitors: 517 nCPM
- neutrophil progenitors: 498 nCPM
- sertoli cells: 451 nCPM
Immune cell
- myeloid DC: 13 nTPM
- plasmacytoid DC: 12 nTPM
- non-classical monocyte: 9.6 nTPM
- intermediate monocyte: 8.6 nTPM
- classical monocyte: 7.7 nTPM
- basophil: 6.1 nTPM
Brain region
- white matter: 32 nTPM
- medulla oblongata: 28 nTPM
- basal ganglia: 27 nTPM
- hypothalamus: 24 nTPM
- pons: 23 nTPM
- thalamus: 23 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.99
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.04
- DepMap mean gene effect
- -0.02
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- FYVE zinc finger
- WD40 repeat
- Zinc finger, FYVE/PHD-type
- Zinc finger, RING/FYVE/PHD-type
- WD40/YVTN repeat-like-containing domain superfamily
- Zinc finger, FYVE-related
- WD40 repeat, conserved site
- PAC1/LIS1-like, WD-40 repeat
- WD40-repeat-containing domain superfamily
- WD repeat and FYVE domain-containing protein 1/2
- WD domain, G-beta repeat
- FYVE zinc finger
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of WDFY2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads WDFY2 as an antibody target. Whether an autoantibody or antibody against WDFY2 could matter depends on whether native WDFY2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
WDFY2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label WDFY2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...